Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 5 | 2026 | 1399 | 1.690 |
Why?
|
| Nylons | 5 | 2016 | 10 | 1.550 |
Why?
|
| Chromatin | 3 | 2017 | 499 | 1.170 |
Why?
|
| Metaphase | 1 | 2026 | 34 | 0.970 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2026 | 743 | 0.850 |
Why?
|
| DNA Repeat Expansion | 1 | 2022 | 31 | 0.750 |
Why?
|
| Genome, Human | 2 | 2022 | 1321 | 0.540 |
Why?
|
| Iron-Binding Proteins | 1 | 2017 | 25 | 0.530 |
Why?
|
| Friedreich Ataxia | 1 | 2017 | 29 | 0.530 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 28 | 0.530 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 419 | 0.470 |
Why?
|
| Sequence Analysis, DNA | 2 | 2022 | 1692 | 0.460 |
Why?
|
| Drug Design | 1 | 2014 | 156 | 0.390 |
Why?
|
| Genome | 1 | 2014 | 451 | 0.350 |
Why?
|
| Binding Sites | 3 | 2016 | 1133 | 0.280 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1833 | 0.280 |
Why?
|
| Neoplasms | 1 | 2022 | 3016 | 0.260 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 83 | 0.260 |
Why?
|
| Estradiol | 1 | 2008 | 460 | 0.230 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 307 | 0.220 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 129 | 0.220 |
Why?
|
| Imidazoles | 2 | 2016 | 219 | 0.220 |
Why?
|
| Pyrroles | 2 | 2016 | 188 | 0.210 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2022 | 28 | 0.190 |
Why?
|
| Glucuronosyltransferase | 1 | 2022 | 63 | 0.180 |
Why?
|
| Introns | 1 | 2022 | 278 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 223 | 0.160 |
Why?
|
| Base Sequence | 1 | 2022 | 2730 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2026 | 3748 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 83 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2017 | 229 | 0.130 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 47 | 0.120 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 20 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 2323 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2904 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2465 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2014 | 315 | 0.100 |
Why?
|
| Humans | 6 | 2026 | 131163 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 708 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1363 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 373 | 0.090 |
Why?
|
| Cell Line | 1 | 2016 | 2552 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2014 | 801 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2014 | 1064 | 0.080 |
Why?
|
| Computational Biology | 1 | 2014 | 862 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1105 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 53 | 0.070 |
Why?
|
| Estrous Cycle | 1 | 2008 | 40 | 0.070 |
Why?
|
| Diastole | 1 | 2008 | 181 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 274 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 241 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1939 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 325 | 0.060 |
Why?
|
| Genomics | 1 | 2014 | 1621 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2008 | 323 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 639 | 0.060 |
Why?
|
| Rats | 2 | 2008 | 3370 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 2406 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 549 | 0.050 |
Why?
|
| Heart | 1 | 2008 | 650 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2016 | 96 | 0.030 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 9 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2014 | 61 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 116 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 716 | 0.020 |
Why?
|
| Animals | 2 | 2008 | 33912 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 808 | 0.020 |
Why?
|
| Male | 2 | 2008 | 64957 | 0.010 |
Why?
|
| Female | 1 | 2008 | 70963 | 0.000 |
Why?
|